Abstract Details

Title Effectiveness of a Medical ��ɫ�� Activity on Improving Knowledge of Prognostic Factors in Multiple Sclerosis among Neurologists

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 375

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Thomas Finnegan, Jr., PhD (Medscape ��ɫ��) PRESENTER	Dr. Finnegan has nothing to disclose.
	No disclosure on file
Thomas F. Scott, MD (AHN Neurology)	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.

��ɫ����